BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20920981)

  • 1. Association of DNMT1 gene polymorphisms in exons with sporadic infiltrating ductal breast carcinoma among Chinese Han women in the Heilongjiang Province.
    Xiang G; Zhenkun F; Shuang C; Jie Z; Hua Z; Wei J; Da P; Dianjun L
    Clin Breast Cancer; 2010 Oct; 10(5):373-7. PubMed ID: 20920981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
    Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
    Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China.
    Sun MY; Yang XX; Xu WW; Yao GY; Pan HZ; Li M
    Genet Mol Res; 2012 Dec; 11(4):4330-41. PubMed ID: 23079992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province.
    Fu Z; Li D; Jiang W; Wang L; Zhang J; Xu F; Pang D; Li D
    Breast Cancer Res Treat; 2010 Feb; 120(1):195-202. PubMed ID: 19585237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women.
    Fu Z; Chen S; Liu S; Han S; Gao X; Li D; Li D
    Oncotarget; 2016 Sep; 7(36):57970-57977. PubMed ID: 27517320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of functional -509C>T polymorphism in the TGF-β1 gene with infiltrating ductal breast carcinoma risk in a Russian Western Siberian population.
    Babyshkina N; Malinovskaya E; Stakheyeva M; Volkomorov V; Slonimskaya E; Maximov V; Cherdyntseva N
    Cancer Epidemiol; 2011 Dec; 35(6):560-3. PubMed ID: 21470928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
    Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
    J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
    Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
    Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of CD28 gene polymorphisms in patients with sporadic breast cancer in a Chinese Han population in Northeast China.
    Chen S; Zhang Q; Shen L; Liu Y; Xu F; Li D; Fu Z; Yuan W; Pang D; Li D
    PLoS One; 2012; 7(10):e48031. PubMed ID: 23133541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 genotypes and haplotypes associated with risk of breast cancer.
    Buyru N; Altinisik J; Demokan S; Dalay N
    Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.